Fig. 1From: The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)Kaplan–Meier survival curves for progression-free survival (PFS) and overall survival (OS) in patients with PTCL-NOS, including MTV, TLG, D-5PS, Ann Arbor and IPIBack to article page